Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in Patients
Clinical trial NCT01915576 · COMPLETED
Trial details
- NCT number
- NCT01915576
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2016-07-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.